Showing results (1041-1050 of 1,131) with videos related to
Sort By:
Pageof 114
Frontiers in Pharmacology|July 7, 2020
Potential Mechanism of Dermal Wound Treatment With Preparations From the Skin Gel of Arabian Gulf Catfish: A Unique Furan Fatty Acid (F6) and Cholesta-3,5-Diene (S5) Recruit Neutrophils and Fibroblasts to Promote Wound HealingJassim M Al-Hassan, Aleksander Hinek, Waleed M Renno, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancerGerhardt Attard, Alison H M Reid, Roger A'Hern, et al.The Lancet. Oncology|October 13, 2012
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage studyDavid Olmos, Daniel Brewer, Jeremy Clark, et al.Clinical Breast Cancer|August 30, 2016
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II StudyDenise A Yardley, James Reeves, E Claire Dees, et al.Nature Communications|August 17, 2018
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapySusan E Logue, Eoghan P McGrath, Patricia Cleary, et al.Journal of Inherited Metabolic Disease|May 17, 2026
Natural History of Morquio A SyndromeShunji Tomatsu, Kimberly Klipner, Marie Sahou, et al.Protein Expression and Purification|October 28, 2015
A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastorisFabrice Cerini, Hubert Gaertner, Knut Madden, et al.The Lancet. Rheumatology|November 2, 2022
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trialsTeny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, et al.Scientific Reports|October 8, 2025
Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapyJosh Thomas Georgy, Soumya Susan Regi, Rosh Varghese Georgy, et al.Kidney International Reports|December 11, 2020
A Systematic Study of the Prevalence and Risk Factors of CKD in Uddanam, IndiaBalaji Gummidi, Oommen John, Arpita Ghosh, et al.Pageof 114